Literature DB >> 30742939

Hypoxia induces actin cytoskeleton remodeling by regulating the binding of CAPZA1 to F-actin via PIP2 to drive EMT in hepatocellular carcinoma.

Deng Huang1, Li Cao1, Le Xiao2, Ju-Xian Song3, Yu-Jun Zhang1, Ping Zheng1, Shu-Guo Zheng4.   

Abstract

Studies have shown that hypoxia can induce cytoskeletal injury and remodeling through the activation of the RhoA/ROCK signaling pathway by hypoxia-inducible factor-1α (HIF-1α). Our previous study confirmed that CAPZA1 can modulate EMT by regulating actin cytoskeleton remodeling. However, the relationship between HIF-1α and CAPZA1 has not been illustrated. Therefore, this study aimed to investigate the mechanism by which hypoxia induces the remodeling of the actin cytoskeleton by regulating CAPZA1 in hepatocellular carcinoma (HCC) cells. In the present study, we showed that the low expression of CAPZA1 promotes HCC cell invasion and migration in vitro and in vivo by regulating actin cytoskeleton remodeling to drive EMT. Furthermore, we found that the combination of PIP2 and CAPZA1 enables CAPZA1 to be released from the barbed end of F-actin, which in turn drives the remodeling of the actin cytoskeleton. Finally, we confirmed that hypoxia increases PIP2 levels and its binding to CAPZA1 in HCC cells via the HIF-1α/RhoA/ROCK1 pathway. Thus, CAPZA1 and PIP2 could be therapeutic targets to inhibit the invasion and migration promoted by hypoxia in HCC cells.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hypoxia-inducible factor-1α (HIF-1α); Invasion; Migration; ROCK1; RhoA

Mesh:

Substances:

Year:  2019        PMID: 30742939     DOI: 10.1016/j.canlet.2019.01.042

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  18 in total

1.  Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn-AhR-AQP4 signaling pathway.

Authors:  Lisha Du; Zikang Xing; Bangbao Tao; Tianqi Li; Dan Yang; Weirui Li; Yuanting Zheng; Chunxiang Kuang; Qing Yang
Journal:  Signal Transduct Target Ther       Date:  2020-02-21

Review 2.  Susceptibility of cytoskeletal-associated proteins for tumor progression.

Authors:  Abiola Abdulrahman Ayanlaja; Xiaoliang Hong; Bo Cheng; Han Zhou; Kouminin Kanwore; Piniel Alphayo-Kambey; Lin Zhang; Chuanxi Tang; Muinat Moronke Adeyanju; Dianshuai Gao
Journal:  Cell Mol Life Sci       Date:  2021-12-29       Impact factor: 9.261

3.  The sodium/myo-inositol co-transporter SLC5A3 promotes non-small cell lung cancer cell growth.

Authors:  Zihan Cui; Chuanyong Mu; Zhichao Wu; Shu Pan; Zewen Cheng; Zhi-Qing Zhang; Jun Zhao; Chun Xu
Journal:  Cell Death Dis       Date:  2022-06-27       Impact factor: 9.685

4.  Overview of distinct 5-methylcytosine profiles of messenger RNA in human hepatocellular carcinoma and paired adjacent non-tumor tissues.

Authors:  Qiyao Zhang; Qingyuan Zheng; Xiao Yu; Yuting He; Wenzhi Guo
Journal:  J Transl Med       Date:  2020-06-22       Impact factor: 5.531

Review 5.  Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy.

Authors:  Hong-Tao Chen; Hao Liu; Min-Jie Mao; Yuan Tan; Xiang-Qiong Mo; Xiao-Jun Meng; Meng-Ting Cao; Chu-Yu Zhong; Yan Liu; Hong Shan; Guan-Min Jiang
Journal:  Mol Cancer       Date:  2019-05-24       Impact factor: 27.401

6.  Inhibition of chemotherapy-related breast tumor EMT by application of redox-sensitive siRNA delivery system CSO-ss-SA/siRNA along with doxorubicin treatment.

Authors:  Xuan Liu; Xue-Qing Zhou; Xu-Wei Shang; Li Wang; Yi Li; Hong Yuan; Fu-Qiang Hu
Journal:  J Zhejiang Univ Sci B       Date:  2020-03       Impact factor: 3.066

Review 7.  Controversies around epithelial-mesenchymal plasticity in cancer metastasis.

Authors:  Elizabeth D Williams; Dingcheng Gao; Andrew Redfern; Erik W Thompson
Journal:  Nat Rev Cancer       Date:  2019-10-30       Impact factor: 60.716

Review 8.  Epithelial-to-Mesenchymal Transition in the Light of Plasticity and Hybrid E/M States.

Authors:  Laura Bornes; Guillaume Belthier; Jacco van Rheenen
Journal:  J Clin Med       Date:  2021-05-29       Impact factor: 4.241

9.  Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn-AhR-AQP4 signaling pathway.

Authors:  Lisha Du; Zikang Xing; Bangbao Tao; Tianqi Li; Dan Yang; Weirui Li; Yuanting Zheng; Chunxiang Kuang; Qing Yang
Journal:  Signal Transduct Target Ther       Date:  2020-02-21

Review 10.  Cortactin in Epithelial-Mesenchymal Transition.

Authors:  Rong Ji; Xiao-Juan Zhu; Zhi-Rong Wang; Li-Qiang Huang
Journal:  Front Cell Dev Biol       Date:  2020-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.